Pioneering research utilizes high-throughput single-cell sequencing to demystify the microbial universe within activated sludge, a cornerstone of wastewater treatment. This study has unearthed a ...
Rare diseases (RD) are more common than you might think. For every 20 people you know, one is likely affected by a rare disease. Of the 7,000 known RD conditions, 80% have a genetic origin, yet over ...
Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic ...
News-Medical.Net on MSN
Element Biosciences introduces VITARI™, redefining what high-throughput sequencing makes possible
Element Biosciences Inc. today announced VITARI, the first ever high-throughput benchtop sequencing system capable of delivering a high-quality whole genome at $100. With the introduction of VITARI, ...
By Dusty Vyas, Senior Scientist at LGC Biosearch Technologies Targeted GBS The application of targeted genotyping by sequencing (targeted GBS) in | Genetics And Genomics ...
On January 21st, the Thalassemia International Federation (TIF) and BGI Genomics jointly hosted an educational webinar focused on thalassemia prevention in high-prevalence regions. The event featured ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...
Preliminary results from a first-in-human trial of AMT-116, a topoisomerase I inhibitor containing antibody-drug conjugate (ADC), in patients with advanced solid tumors. A novel oral microtubule ...
Element Biosciences is going toe-to-toe with gene-sequencing giant Illumina, unveiling a device that can read DNA for half the price of the industry leader’s technology. On Thursday, Element ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results